Literature DB >> 20041292

Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Mercè Padró1, José A Castillo, Livia Gómez, Jesús Joglar, Pere Clapés, Carme de Bolós.   

Abstract

Iminosugars are monosaccharide analogues that have been demonstrated to be specific inhibitors for glycosidases and are currently used therapeutically in several human disorders. N-alkylated derivatives of D-fagomine and (2R,3S,4R,5S)-2-(hydroxymethyl)-5-methylpyrrolidine-3,4-diol with aliphatic chains were tested in eight human cancer cell lines to analyze their cytotoxicity and the inhibitory effect in the activities of specific glycosidases. Results indicate that these compounds were more cytotoxic as the length of the alkyl chain increases. N-dodecyl-D-fagomine inhibited specifically the alpha-D-glucosidase activity in cell lysates, whereas no effect was detected in other glycosidases. The N-dodecyl derivative of (2R,3S,4R,5S)-2-(Hydroxymethyl)-5-methylpyrrolidine-3,4-diol induced specific inhibition against alpha-L-fucosidase in cell lysates. Our results indicated that the length of the alkyl chain linked to the iminosugars determine their cytotoxicity as well as the inhibitory effect on the enzymatic activities of specific glycosidases, in human cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20041292     DOI: 10.1007/s10719-009-9276-3

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  18 in total

Review 1.  Glycosidase inhibitors as potential HIV entry inhibitors?

Authors:  Inmaculada Robina; Antonio J Moreno-Vargas; Ana T Carmona; Pierre Vogel
Journal:  Curr Drug Metab       Date:  2004-08       Impact factor: 3.731

Review 2.  Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists.

Authors:  B Winchester; G W Fleet
Journal:  Glycobiology       Date:  1992-06       Impact factor: 4.313

3.  Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease.

Authors:  Liang Yu; Kyoko Ikeda; Atsushi Kato; Isao Adachi; Guillaume Godin; Philippe Compain; Olivier Martin; Naoki Asano
Journal:  Bioorg Med Chem       Date:  2006-08-21       Impact factor: 3.641

4.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Authors:  T Cox; R Lachmann; C Hollak; J Aerts; S van Weely; M Hrebícek; F Platt; T Butters; R Dwek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

Review 5.  Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.

Authors:  Terry D Butters; Raymond A Dwek; Frances M Platt
Journal:  Glycobiology       Date:  2005-05-18       Impact factor: 4.313

6.  Fructose-6-phosphate aldolase in organic synthesis: preparation of D-fagomine, N-alkylated derivatives, and preliminary biological assays.

Authors:  José A Castillo; Jordi Calveras; Josefina Casas; Montserrat Mitjans; M Pilar Vinardell; Teodor Parella; Tomoyuki Inoue; Georg A Sprenger; Jesús Joglar; Pere Clapés
Journal:  Org Lett       Date:  2006-12-21       Impact factor: 6.005

7.  Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.

Authors:  N Zitzmann; A S Mehta; S Carrouée; T D Butters; F M Platt; J McCauley; B S Blumberg; R A Dwek; T M Block
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

8.  Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus.

Authors:  A Mitrakou; N Tountas; A E Raptis; R J Bauer; H Schulz; S A Raptis
Journal:  Diabet Med       Date:  1998-08       Impact factor: 4.359

Review 9.  Neuraminidase inhibitors as antiviral agents.

Authors:  I V Alymova; G Taylor; A Portner
Journal:  Curr Drug Targets Infect Disord       Date:  2005-12

10.  Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.

Authors:  Pi-Hui Liang; Wei-Chieh Cheng; Yi-Ling Lee; Han-Pang Yu; Ying-Ta Wu; Yi-Ling Lin; Chi-Huey Wong
Journal:  Chembiochem       Date:  2006-01       Impact factor: 3.164

View more
  2 in total

1.  Pharmacokinetics, Tissue Distribution, and Elimination of Three Active Alkaloids in Rats after Oral Administration of the Effective Fraction of Alkaloids from Ramulus Mori, an Innovative Hypoglycemic Agent.

Authors:  Shuang Yang; Jiaqi Mi; Zhihao Liu; Baolian Wang; Xuejun Xia; Renyun Wang; Yuling Liu; Yan Li
Journal:  Molecules       Date:  2017-09-26       Impact factor: 4.411

2.  D(-)lentiginosine-induced apoptosis involves the intrinsic pathway and is p53-independent.

Authors:  A Minutolo; S Grelli; F Marino-Merlo; F M Cordero; A Brandi; B Macchi; A Mastino
Journal:  Cell Death Dis       Date:  2012-07-26       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.